Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-214940
Filing Date
2017-06-27
Accepted
2017-06-27 16:31:06
Documents
1
Group Members
AARON I. DAVISBOXER ASSET MANAGEMENT INC.BRASLYN LTD.CHRISTOPHER FUGLESANGIVAN M. LIEBERBURGJOE LEWISMVA INVESTORS, LLCNEIL REISMANRODNEY W. LAPPESHEHAN B. DISSANAYAKE

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d408880dsc13da.htm SC 13D/A 198354
  Complete submission text file 0001193125-17-214940.txt   200196
Mailing Address 11682 EL CAMINO REAL SUITE 320 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 320 SAN DIEGO CA 92130 (858) 400-3112
Boxer Capital, LLC (Filed by) CIK: 0001465837 (see all company filings)

EIN.: 203828456 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Subject) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87670 | Film No.: 17932714
SIC: 2834 Pharmaceutical Preparations